Renal Impairment: Clinical Trials

3 trials for Renal Impairment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Terminated 1, Unknown 1
Phase 21Unknown 1

Follow Renal Impairment: new trials by email Literature Review of Renal Impairment trials Research Report on Renal Impairment

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation
delayed, low-dose CNI, BU-CNI, BU-Everolimus - Renal Impairment, Liver Transplantation
Phase 2 / Phase 3UnknownUniversity of Regensburg452011-06-012011-07-01
Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment
dutogliptin, placebo, sitagliptin - Type 2 Diabetes Mellitus, Renal Impairment
Phase 3TerminatedPhenomix3602009-08-012010-02-03
Olmesartan Medoxomil in Hypertension and Renal Impairment
Olmesartan medoxomil, Losartan, Furosemide oral tablets - Essential Hypertension, Renal Impairment
Phase 3CompletedSankyo Pharma Gmbh3932003-08-012010-10-14

Narrower conditions

Renal Insufficiency (3)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Essential Hypertension (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Cardiovascular Diseases (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hypertension (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Vascular Diseases (1)

Interventions

Furosemide (1)  ·  Losartan (1)  ·  Olmesartan Medoxomil (1)  ·  Sitagliptin Phosphate (1)  ·  cni protein, Drosophila (1)  ·  dutogliptin (1)

Sponsors

Phenomix (1)  ·  Sankyo Pharma Gmbh (1)  ·  University of Regensburg (1)

Countries

Germany (2)  ·  Russia (1)  ·  Ukraine (1)  ·  United States (1)

Top investigators

Andreas A Schnitzbauer, MD (1)  ·  Hans J Schlitt, MD (1)  ·  P. U. Witte, MD, PhD (1)